Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That would be great.
The big picture is where we are headed. The tipping point is coming this week when Trump and Fauci put Leronlimab out front and center.
Major, the shorts that think the science is fluff and put this in there box of indicators are toast. Bottom line is the science is safe and going to perform.
What you see is what we are going to continue to get as more patients are injected and the results flow in.
This is going to be a great run.
You missed this one. No fluff here. You guys put this in a box and don’t do your homework.
This is a blip on the radar in terms of where we will be by Friday. Leronlimab is going to continue to perform and the attention is at a fraction of where it will be by weeks end. Buckle up.
Let the show begin!
What are you an auctioneer. Are you headed to $4, do I hear $5.
Stickie that link and replace the current Fox Link. This goes straight to the meat.
The guy that pitched me the story 8 years ago has 5M shares. It’s all relative.
Nice pile. Going to be very stingy w my 550k shares.
I’m very interested in seeing what type of volume is going to churn through the shares tomorrow. 30M plus?
As for SP that’s going to be a show I can’t wait to watch.
Been waiting for some genuine excitement for quite a long time - close to 8 years. Accumulated a boat load of shares and am going to be quite stingy with every single one.
I know many will disagree but I would be quite pleased with a buy out at $10B/$15 share and move on.
Don’t forget how much $ this is going to bring into the company’s coffers. Converting warrants is a good thing. That is different than selling the shares. We shall see.
Good luck with that play.
No. Converting warrants will have no impact on SP or trading.
Andy, your talking AT Investors who have been here a very long time, myself since 2012. We are not going to prove anything to you. We are already educated with everything this company has been doing and the multiple potential indications. Understand your audience.
In Nader’s last Proactive he was asked about BLA. He is now talking about bleeding into first week or so of April. That was my take. As we all know he’s the king of stringing things along - all for very good reason of course.
So get your S#%t together and start building a position. This is going up regardless of Naders weaknesses. The science isn’t going to be stopped.
Agreed A17. All good points.
The weak link is Naders inexperience to navigate the next level. He would be wise to relinquish that responsibility by handing the reins to the right seasoned professional with the skill set and network to get it done. IMO anyone who thinks that is not a concern is simply not paying attention.
Thank you for clarifying. I agree with everything you say.
My point is all we have right now for results is for patients that are experiencing ARDS. It would stand to reason that it would be effective in preventing if administered as soon as a patient has symptoms.
Given the vast majority that contract Covid-19 do not experience ARDS the question will be when does a physician make the decision to inject? This also brings up the high COGS associated with this monoclonal antibody.
Good luck to you Misiu. Your confidence and insight into the science has always boosted my confidence.
Your the Medical Professional Misiu so you understand the clinical situation better than I do.
My take is that the buzz is about the impact Leronlimab is having on saving lives with the very sick in regards to ARDS which is the killer. That is what drove the SP up on Friday and it will be the driver this coming week.
If we find out it is successful in early stage and prevents ARDS that’s would be quite a different story. My understanding is at this point we really don’t have any data to support the efficacy at early stage.
If I’m wrong please correct me.
Your input as always is much appreciated.
I am very aware of what is going on.
First of all Leronlimab is for last stage Covid-19 respiratory failure. It’s huge because it may be the answer to saving the very sick. It is on the other hand not a vaccine. Monetizing is going to be tricky given the limited long term demand as the Covid -19 curve is going to flatten. Also COGS for Leronlimab at largest scale is still expensive.
Don’t get me wrong I am very excited about what I see going on with saving these very sick people, however our long term play is HIV and Cancer.
This is going to give us incredible exposure and hopefully a big lift in SP. We need to take advantage of this opportunity and nail down a significant partner and licensing deal to get to the goal line with the meat which is HIV and Cancer.
AIMHO
Seriously? I’d like to see it cross $2.
Andy, Grip beats to his own drum. Culper he is not so put that to rest.
It is becoming increasing clear that Leronlimab is no fluke and in fact has Humira like potential.
The success with treating Covid-19 respiratory failure is yet another example of the efficacy and legitimacy of the MOA.
We are on the precipice of exposing the rest of the world to what many here have known for quite some time: indications abound with this unique monoclonal antibody.
If Leronlimab proves to be the lifesaver with the life threatening stage of Covid-19 think about the credibility and attention TNBC and the Basket Trial will garner.
I don’t want to get too far in front of the carriage but even a skeptic is going to be scratching their head... and for good reason.
Can’t help myself as he leaves himself so ignorantly wide open.
Sounds like The Donald has admitted all his brains are below his waist.
Your party here is over. You best find a new pond to do your quacking in.
Your statement makes it clear you know zip about how pre revenue Biotech works or market fundamentals for that matter. If SP drops and can’t hold its 52 week high for a month its a loser and sell. Thanks Mr. expert.
“Trust me”, are you serious. Your ignorance runuth over edward.
In case you are blind you should know CYDY is not tied to the broad market. Absolutely no correlation. Are you RealDD’s twin?
Bottom of the Barrel as they say. The Duck will be gone soon. One at a time they will take their s#%t show somewhere else.
Eng, you are a very confusing person to take seriously. For the past month you have been screaming scam. Now you are actually saying the science has value.
You have a problem with Nader’s competency. Many would agree on that point. That’s a horse of a different color than ranting Scam.
Your style is offensive and very inconsistent - Seriously what are you doing here? Am I to believe you have no skin in the game yet you spend your days posting about CYDY?
Then why are you here?
Best news I’ve heard all day.
Grip, I don’t think you understand the complication the dosage increase had on the BLA filing.
The Cancer play is a game changer that needs more patients to garner BP attention. Nader is walking this down multiple pathways on limited resources while not giving in to low ball financing.
There are many catalysts in play that can drive the SP up 2-3x in the next few months.
Granted I’m as impatient as you when it comes to delays but it’s all in ones perspective based on the available information.
Don’t base 2020 on everything you can pitch negatively that has happened in the past. I can take the same history and paint an amazing story. While I do not endorse Nader’s persona nor his communication skills he is not going to run Leronlimab into a ditch.
If we are still sitting in the $1 range by the end of the year I’ll be moving towards your level of distrust and confidence. The reality is COVID-19 has thrust our world into mass confusion and uncertainty. That’s not helping advance Leronlimab’s clinical data other than a shot at helping COVID-19 respiratory failure.
Hopefully the world can get back to a semblance of normalcy in the next couple of months.
GLTU Grip - and by the way you are certainly not Culper.
Yes Grip, they are all valid questions that will be answered in the coming days. Do you really think a physician would use Leronlimab on four patients with no confidence it could save lives.
I’m in favor of letting the science speak for itself. This is an opportunity to gain the type of exposure that could validate the legitimacy of Leronlimab. Patterson is just presenting the facts and the FDA and overseeing physician are making the call. If I were the patient embarking on my last breath I’d want the option.
Grip, the level of financial resources being diverted to COVID-19 is minimal and inconsequential in terms of compromising the BLA.
The MOA is scientifically compelling enough to give Leronlimab an opportunity to save lives. The level of efficacy or actual economic gain for CYDY is a gamble but a responsibility proven by the decision of the overseeing physician in selecting Leronlimab over alternate drugs.
The talk that Nader is just trying to blindly pump Leronlimab in the COVID-19 space is another telegraphed play by those that are already vehemently bashing CYDY.
If I believed this was just another fluff PR strategy I would not be invested. There is no sense in knowingly going down a path that is a dead end. I’m of the mind to see what happens with these very sick patients - good for Nader for having the guts to take on the risk.
No inside info obviously. Just speculation. At what point will an update be PR’d regarding the status of the four patients injected. Maybe tomorrow, maybe in a week. It’s going to happen, that’s all.
Ditto.
“Fake Trade”. That’s a new one, never heard of that. I have feeling you don’t pay your bets.
When should we expect an update on the status of the four patients that were injected in NY?